SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001640334-21-000986
Filing Date
2021-04-21
Accepted
2021-04-20 18:05:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC-13D clcs_sc13d.htm SC 13D 36381
2 EX-1 clcs_ex1.htm EX-1 60506
3 EX-2 clcs_ex2.htm EX-2 48690
  Complete submission text file 0001640334-21-000986.txt   146912
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Subject) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91841 | Film No.: 21838976
SIC: 2834 Pharmaceutical Preparations

Mailing Address 341 LAKEWOOD DRIVE BLOOMFIELD HILLS MI 48304
Business Address
Soave Darlene (Filed by) CIK: 0001856892 (see all company filings)

Type: SC 13D